Triheptanoin Treatment Trial for Patients With Long-chain Fatty Acid Beta-oxidation Defects
Status:
Withdrawn
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if administration Triheptanoin is an effective
treatment for defects of the long-chain fatty acid beta-oxidation in young adults or adults.
Period of treatment and follow-up will be 16 months.